Acme United Corporation demonstrated steady revenue growth from fiscal year 2023 through 2025, reaching $196.5 million in revenue in FY2025 with improving operating income margins. The recent acquisition of My Medic in January 2026 marks a significant expansion into tactical and emergency response products, bringing new intellectual property and direct-to-consumer channels, albeit with integration risks. Operational cash flow remains robust despite a marked increase in capital expenditures linked to growth initiatives. The company maintains strong liquidity and has extended its revolving credit facility through mid-2027, supporting both acquisitions and working capital needs. Dividends have steadily increased while share repurchases are subdued, pointing to prudent cash allocation amid expansion.